產(chǎn)品說明：

• 貨號：PS2-DEFA-1K,2K,3K,5K,10K。
• 外觀：黃色、橙色至褐色固體。
• 溶解度：:>5 mg/mL在熱水，氯仿/甲醇，DMSO中。
• 穩(wěn)定性：在-20°C下1年，干燥，避光。
• CAS 號：1236288-25-7。
• 分子量（PEG）:1K,2K,3.4K,5K,10K。

處理和使用：

DSPE PEG FA應(yīng)始終保持低溫干燥狀態(tài)。使用前立即準備新鮮溶液。

避免頻繁解凍和冷凍。有關(guān)使用本產(chǎn)品的更多信息，請訪問ponsure。

存儲條件：

DSPE PEG FA應(yīng)在-20℃下儲存。干燥?？稍诙栊詺怏w下處理材料以獲得良好穩(wěn)定性。12個月后重新測試材料。

相關(guān)產(chǎn)品推薦：

DSPE-PEG-NH2, DSPE-PEG-COOH

DSPE-PEG-NHS ,DSPE-PEG-FA

DSPE-PEG-SH,DSPE-PEG-MAL

參考文獻：

• Bubble-generating nano-lipid carriers for ultrasound/CT imaging-guided efficient tumor therapy------ International Journal of Pharmaceutics（IF=3.862）
• Nasopharyngeal cancer combination chemoradiation therapy based on folic acid modified, gefitinib and yttrium 90 co-loaded, core-shell structured lipid-polymer hybrid nanoparticles------ Biomedicine & Pharmacotherapy（IF=3.457）
• Targeted delivery of in situ PCR-amplified Sleeping Beauty transposon genes to cancer cells with lipid-based nanoparticle-like protocells------ Biomaterials（IF=10.273）
• Cancer cell targeting, controlled drug release and intracellular fate of biomimetic membrane-encapsulated drug-loaded nano-graphene oxide nanohybrids------ Journal of Materials Chemistry B（IF=4.776）
• In vitro and in vivo evaluation of folate-mediated PEGylated nanostructured lipid carriers for the efficient delivery of furanodiene.
• NIR stimulus-responsive core–shell type nanoparticles based on photothermal conversion for enhanced antitumor efficacy through chemo-photothermal therapy------ Nanotechnology(IF=3.404)
• lipid nanobubbles as an ultrasound-triggered artesunate delivery system for imaging-guided,tumor-targeted chemotherapy.
• Facile synthesis of biocompatible MoSe₂ nanoparticles for efficient targeted photothermal therapy of human lung cancer------ RSC Advances（IF=2.963）
• Inhalable dry powder prepared from folic acid-conjugated Docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy.
• Near infrared radiated stimulus-responsive liposomes based on photothermal conversion as drug carriers for co-delivery of CJM126 and cisplatin------ Materials Science and Engineering C（IF=5.08）
• Normalizing Tumor Microenvironment Based on Photosynthetic Abiotic/Biotic Nanoparticles------ ACS Nano（13.709）
• A novel near-infrared triggered dual-targeted nanoplatform for mitochondrial combined photothermal-chemotherapy of cancer in vitro------ Nanotechnology（3.404）
• Folate-decorated and NIR-triggered nanoparticles loaded with platinum(IV)-prodrug plus 5-fluorouracil for targeted and chemo-photothermal combination therapy.
• Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy------ RSC Advances（IF=2.963）

本產(chǎn)品僅用于研究用途，不用于人類或診斷用途。